SSEA-5 Antibody, anti-human
Bioz Star93/100 Bioz rating
5 Citations
Clone:
8e11
Type of antibody:
Primary antibodies
Isotype:
mouse IgG1κ
Applications:
FC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for SSEA-5 Antibody, anti-human

Flow cytometry applications
APC
APC-Vio 770
Biotin
FITC
PE
PE-Vio 770
PerCP-Vio 700
VioBlue
VioGreen
pure
Recommended dilution:
1:50
Remark:
Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-126-169, 130-126-199
Description:
Human induced pluripotent stem cells (iPS cells) were stained with Anti-SSEA-5 antibodies or with the corresponding isotype control antibodies (left peak) and analyzed with the MACSQuant® Analyzer. The FcR Blocking Reagent has been used to avoid Fc receptor-mediated antibody labeling. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.

Application image
Specifications for SSEA-5 Antibody, anti-human
Overview

Clone 8e11 recognizes the human stage-specific embryonic antigen-5 (SSEA-5) antigen, an oligosaccharide that contains the motif Fucα1-2Galβ1-3GlcNAcβ, also known as the H type-1 (H-1) antigen. SSEA-5 is highly and specifically expressed on undifferentiated embryonic stem cells and pluripotent stem cells. It is also expressed on the surface of cells in the inner cell mass of the human blastocyst during embryogenesis and expression is rapidly down-regulated upon cellular differentiation.

Detailed product information

Technical specifications

Clone
8e11
Clonality
monoclonal
Isotype
mouse IgG1κ
Isotype control
Isotype Control Antibody, mouse IgG1
Host
mouse
Type of antibody
Primary antibodies
Species reactivity
human
Antigen
SSEA-5
Distribution of antigen
stem cells, ES and iPS cells
RRID
AB_2653537, AB_2653538, AB_2653543, AB_2857583, AB_2857580, AB_2905394, AB_2653546, AB_2653539, AB_2653544, AB_2653545, AB_2889755, AB_2653532, AB_2653547, AB_2653531, AB_2889756, AB_2653540, AB_2905395, AB_2653542, AB_2653541

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for SSEA-5 Antibody, anti-human
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?